glutathione and cancer Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Glutathione-mediated nanomedicines for cancer diagnosis
Description
M.HussainI.DingwallC.HooperN
Typical usage rates range from 0.5 to 2 percent peptide concentration
The limited human data includes a pilot study of IV infusion in 2 healthy adults (showing no adverse effects) 3 and an intra-articular injection study where 11 of 12 patients (91.6%) reported significant improvement in knee pain 4
Staying well-hydrated supports optimal bioavailability of the injected nutrients
(4) The experiment in question involved obese murine models, and the scientists commented that there was a 23% increase in glycerol release from adipose tissue within the murine models
